The UK arm of AAIPharma (AAI) is to expand its operations in Edinburgh, creating up to 47 managerial, scientific and administration jobs over the next three years.
AAI is a global contract research organisation providing product development and support services to the pharmaceutical, biotechnology, and medical device industries.
The company’s strategy is to develop clusters of expertise and excellence. Edinburgh will host the pharmacokinetic and pharmacodynamic consulting arm which establishes the ‘therapeutic profile’ of the drugs being tested and supplies recommendations on development strategies. This highlights potential issues and understanding of what happens to the drug once it has been administered. The Edinburgh office will also include statistical resource and business development and proposals resource to support AAI’s international business.
The new project is being supported by a Regional Selective Assistance Grant of £400,000.
Key to AAI Group’s decision to expand in Edinburgh was the availability of skilled staff, proximity to pharmaceutical and biotechnology companies and a supportive business infrastructure. Currently, all existing AAI staff are based at the Technopole in Edinburgh though the company is planning to move to the Riccarton area of the city.
Lena Wilson, chief operating officer of Scottish Enterprise, said: ‘Increasing global recognition of Scotland’s world class scientific and research expertise has contributed to the country’s life sciences industry doubling in size in terms of both jobs and the number of companies over the past five years and successes like today’s announcement today will only help to fuel this growth further.’